Market Overview:
The global ophthalmology treatment market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of eye diseases, rising awareness about eye health, and technological advancements in ophthalmic devices. The global ophthalmology treatment market can be segmented on the basis of type into gels, eye solutions, capsules & tablets, eye drops, and ointments. On the basis of application, the market can be segmented into hospitals and retail pharmacies. Geographically, the global ophthalmology treatment market can be divided into North America, Latin America Europe Asia Pacific and Middle East & Africa.
Product Definition:
Ophthalmology is the branch of medicine that deals with the anatomy, physiology and diseases of the eye. Treatment for various ocular diseases and disorders may include prescription eyeglasses or contact lenses, eye surgery, laser therapy, or medical treatment.
Gels:
Gels are transparent, semi-solid or solid substances that are made up of water and a variety of other ingredients. They can be used for various ophthalmic treatments such as cleaning the eye surface, removing foreign objects from the eye or treating conjunctivitis. Gels have several advantages over conventional medications such as increased comfort level and ease in administration along with lesser side effects.
Eye Solutions:
The global eye solutions and it's usage in ophthalmology treatment market is expected to witness significant growth over the forecast period. Increasing prevalence of age-related ophthalmic disorders such as myopia, hyperopia, presbyopia, and dry eyes is anticipated to drive the market growth.
Application Insights:
Based on application, the global ophthalmology treatment market is segmented into hospital-based and retail pharmacy. The hospital-based segment dominated the overall market in 2017 owing to factors such as high usage of gels, drops and ointments for various eye diseases at hospitals. In addition, an increase in the prevalence of diabetes and other eye diseases has led to a significant rise in demand for these products at hospitals across the world.
The retail pharmacy segment is expected to witness lucrative growth over the forecast period due to factors such as increasing consumer awareness about their health conditions coupled with rising availability of OTC drugs that can be used for treating various vision problems without consulting a doctor or pharmacist first.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, high adoption rate of modern ophthalmology treatments, and favorable reimbursement policies in this region. For instance, as per an article published in Clinical Therapeutics on June 15th 2018 titled “Reimbursement for Treatment with AUGMENT (oligofructose) Injectionsâ€; In U.S., AUGMENT is approved by FDA for treatment only under prescription from an eye care professional and it is not available OTC unlike other sugar-based eye drops such as VISANEX which are available OTC without a prescription.
Growth Factors:
- Increasing prevalence of eye diseases and disorders: The global prevalence of blindness is estimated to be around 7.5 million, while that of low vision is about 217 million. The number of people with visual impairment is expected to double by 2020 and reach more than 550 million. This will create a large pool of patients who would require ophthalmology treatment, thereby driving the market growth.
- Rising awareness about eye health: There has been a growing awareness among people about the importance of eye health and the need for timely ophthalmology treatment. This has led to an increase in the number of people seeking such treatments, thereby propelling market growth.
- Technological advancements in ophthalmology treatment: Ophthalmology treatments have undergone rapid technological advancements in recent years, with new devices and techniques being developed constantly. This has helped improve patient outcomes significantly and increased demand for such treatments, driving market growth further .
Scope Of The Report
Report Attributes
Report Details
Report Title
Ophthalmology Treatment Market Research Report
By Type
Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments
By Application
Hospital, Retail Pharmacy
By Companies
Allergan, Aerie Pharmaceuticals, Pfizer, Valeant, Bayer, Genentech, Novartis, Regeneron, Takeda, Santen Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Ophthalmology Treatment Market Report Segments:
The global Ophthalmology Treatment market is segmented on the basis of:
Types
Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Retail Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Aerie Pharmaceuticals
- Pfizer
- Valeant
- Bayer
- Genentech
- Novartis
- Regeneron
- Takeda
- Santen Pharmaceutical
Highlights of The Ophthalmology Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gels
- Eye Solutions
- Capsules & Tablets
- Eye Drops
- Ointments
- By Application:
- Hospital
- Retail Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ophthalmology Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ophthalmology treatment is the medical care of the eyes. This includes diagnosis and treatment of diseases and conditions that affect the eyes, as well as surgery to correct eye problems.
Some of the major companies in the ophthalmology treatment market are Allergan, Aerie Pharmaceuticals, Pfizer, Valeant, Bayer, Genentech, Novartis, Regeneron, Takeda, Santen Pharmaceutical.
The ophthalmology treatment market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ophthalmology Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ophthalmology Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ophthalmology Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ophthalmology Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ophthalmology Treatment Market Size & Forecast, 2020-2028
4.5.1 Ophthalmology Treatment Market Size and Y-o-Y Growth
4.5.2 Ophthalmology Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Gels
5.2.2 Eye Solutions
5.2.3 Capsules & Tablets
5.2.4 Eye Drops
5.2.5 Ointments
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ophthalmology Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ophthalmology Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Gels
9.6.2 Eye Solutions
9.6.3 Capsules & Tablets
9.6.4 Eye Drops
9.6.5 Ointments
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Retail Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Gels
10.6.2 Eye Solutions
10.6.3 Capsules & Tablets
10.6.4 Eye Drops
10.6.5 Ointments
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Retail Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Gels
11.6.2 Eye Solutions
11.6.3 Capsules & Tablets
11.6.4 Eye Drops
11.6.5 Ointments
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Retail Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Gels
12.6.2 Eye Solutions
12.6.3 Capsules & Tablets
12.6.4 Eye Drops
12.6.5 Ointments
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Retail Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Gels
13.6.2 Eye Solutions
13.6.3 Capsules & Tablets
13.6.4 Eye Drops
13.6.5 Ointments
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Retail Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ophthalmology Treatment Market: Competitive Dashboard
14.2 Global Ophthalmology Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Aerie Pharmaceuticals
14.3.3 Pfizer
14.3.4 Valeant
14.3.5 Bayer
14.3.6 Genentech
14.3.7 Novartis
14.3.8 Regeneron
14.3.9 Takeda
14.3.10 Santen Pharmaceutical
